Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125135953 | 12513595 | 3 | F | 201311 | 20160913 | 20160630 | 20160915 | EXP | US-JNJFOC-20160525792 | JANSSEN | 36.87 | YR | A | M | Y | 0.00000 | 20160915 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125135953 | 12513595 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 15 MG AND THEN 20 MG ONCE DAILY | Y | N | UNKNOWN | 0 | TABLET | ||||||
| 125135953 | 12513595 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 15 MG AND THEN 20 MG ONCE DAILY | Y | N | UNKNOWN | 0 | TABLET | ||||||
| 125135953 | 12513595 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 15 MG AND THEN 20 MG ONCE DAILY | Y | N | UNKNOWN | 0 | TABLET | ||||||
| 125135953 | 12513595 | 4 | PS | XARELTO | RIVAROXABAN | 1 | Oral | 15 MG AND THEN 20 MG ONCE DAILY | Y | N | UNKNOWN | 22406 | TABLET | ||||||
| 125135953 | 12513595 | 5 | SS | LOVENOX | ENOXAPARIN SODIUM | 1 | Unknown | U | 0 | 40 | MG | UNSPECIFIED | |||||||
| 125135953 | 12513595 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 0 | 1000 | MG | UNSPECIFIED | BID | |||||||
| 125135953 | 12513595 | 7 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 125135953 | 12513595 | 8 | C | AZOR | AMLODIPINE BESYLATEOLMESARTAN MEDOXOMIL | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125135953 | 12513595 | 1 | Pulmonary embolism |
| 125135953 | 12513595 | 2 | Pulmonary embolism |
| 125135953 | 12513595 | 3 | Thrombosis prophylaxis |
| 125135953 | 12513595 | 4 | Thrombosis prophylaxis |
| 125135953 | 12513595 | 5 | Thrombosis prophylaxis |
| 125135953 | 12513595 | 6 | Product used for unknown indication |
| 125135953 | 12513595 | 7 | Product used for unknown indication |
| 125135953 | 12513595 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125135953 | 12513595 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125135953 | 12513595 | Abdominal pain | |
| 125135953 | 12513595 | Lower gastrointestinal haemorrhage | |
| 125135953 | 12513595 | Rectal haemorrhage | |
| 125135953 | 12513595 | Treatment noncompliance |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125135953 | 12513595 | 1 | 20160509 | 0 | ||
| 125135953 | 12513595 | 2 | 201311 | 201511 | 0 | |
| 125135953 | 12513595 | 3 | 20160509 | 0 | ||
| 125135953 | 12513595 | 4 | 201311 | 201511 | 0 | |
| 125135953 | 12513595 | 5 | 2013 | 0 |